Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04258787 · ClinicalTrials.gov registry record
OCT in Fuchs' Dystrophy
A clinical trial of Fuchs Dystrophy and Pseudophakic Bullous Keratopathy, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT04258787 is a study of Fuchs Dystrophy and Pseudophakic Bullous Keratopathy that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04258787, a study of Fuchs Dystrophy and Pseudophakic Bullous Keratopathy, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study using optical coherence tomography (OCT) technology to quantify corneal edema in Fuchs' endothelial dystrophy and predict refractive shift from resolving corneal edema after surgical treatments.
Conditions Studied
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-06-26 |
| Est. Completion | 2028-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04258787
The ClinicalTrials.gov registry entry for NCT04258787 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Fuchs Dystrophy appearing as the primary indexed condition, and to 0 interventions.
NCT04258787 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT04258787 about?
NCT04258787 is a clinical study titled "OCT in Fuchs' Dystrophy". This is an observational study using optical coherence tomography (OCT) technology to quantify corneal edema in Fuchs' endothelial dystrophy and predict refractive shift from resolving corneal edema after surgical treatments.
What is the current status of trial NCT04258787?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2020-06-26. Estimated completion is 2028-06.
What conditions does trial NCT04258787 study?
This clinical trial studies the following conditions: Fuchs Dystrophy, Pseudophakic Bullous Keratopathy.
Who is sponsoring clinical trial NCT04258787?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04258787 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fuchs Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.